Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Current status of
HIV infection
around the world suggests the following: Screening
HIV
antibodies in blood donors is the most promising for the prevention of transfusion associated infections. Besides blood donor screening, the availability of blood tests to be taken anonymously is essential for controlling silent or occult
HIV infection
. Red cell transfusion therapy with CR 1 rich erythrocyte for AIDS patients is also promising. In the US transfusion associated
HIV infection
decreased from 1988 to 1989 by 12% in adults and 39% in children, while that associated with other risk factors such as homosexual acts and IV drug use continued to increase. Rate of
HIV
antibody positive donors also decreased from 0.13 in 1985 to 0.013% in 1988 owing to education, counseling and screening. Surveillance for
HIV
-2 continues although no case was found during 1987-1989 investigations. as of 1989, the highest rate of AIDS patients in Europe was in France followed by Italy, Spain and Germany.
HIV
antibody positive donors drastically decreased in those countries from 0.062 in 1985 to 0.012 in 1989. In contrast, Eastern European nations have shown significant increases. Table II shows rates of
HIV
-1 and
HIV
-2 positive donors in Africa. In Asia 843 AIDS patients were recorded at the end of 1990. IV drug use and prostitution were main factors.
HIV
positive rate among 30 million tested in Japan since 1987 was 0.00018%.
HIV
antibody positive rate was 0./000487%, the highest rate being found in the Tokyo area. Transfusion therapy with CR 1 (c3b receptor) rich erythrocytes given every 2 months to 9 patients of carinii
pneumonia
resulted in the survival rate of 5.9 for more than 15 months, compared with 2/20 for 12 months for those who had occasional blood transfusions. Controls who received no transfusion therapy all died within 10 months. In 1990 heterosexuals are also found to be affected in Japan mostly through infected prostitutes.
...
PMID:[Blood transfusion and HIV infection. Current status in the world and Japan]. 185 67
Bronchoalveolar washout was performed in 130 patients with
pneumonia
during a period of 28 months. Microbiological investigation involved common bacteria, Legionella, fungi, viruses (Cytomegalovirus, herpes, RSV), Mycobacterium, and Pneumocystis carinii. Infection
HIV
was present in 75% of patients. The remaining patients had malignant diseases or severe
pneumonia
. The overall sensitivity of the technique was 65.4% and the positive predictive value was 92%. The technique was less sensitive in cases of bacterial pneumonia (sensitivity = 34.4%). This was attributed to the fact that 82.8% of these cases received antibiotic therapy. Pneumocystis carinii and Mycobacterium tuberculosis were the most common agents (44.8% and 34.5%, respectively). In seven instances the clinical picture was related to cytomegalovirus, although this diagnosis can not be easily done.
...
PMID:[Evaluation of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients at risk]. 186 7
The value of continuous positive airway pressure (CPAP) ventilation via a tight fitting face mask was assessed in eight
HIV
-1 antibody-positive patients with Pneumocystis carinii pneumonia who were in hypoxaemic respiratory failure. All patients were conscious, able to protect their airway and not hypercapnic. Treatment was effective in seven patients. Prior to CPAP, mean (range) arterial oxygen tension was 6.7 (4.7-10.5) kPa in seven patients breathing oxygen via a face mask (FiO2 = 0.6), 6.1 kPa in one patient breathing room air and rose to 9.9 (6.8-12.8) kPa with CPAP (FiO2 = 0.6 and PEEP = 1.3 kPa in six patients and 2.6 kPa in one patient); the mean increase in PaO2 was 3.1 kPa (P less than 0.02). These seven patients experienced a rapid reduction in dyspnoea and their respiratory rate fell from a mean of 40 breaths min-1 to 32 breaths min-1 (P less than 0.001). One patient deteriorated rapidly on CPAP and died: no other complications were seen with this technique. CPAP was continued for a mean of 4.5 days and the seven responders all survived the episode of P. carinii
pneumonia
. We conclude that mask CPAP provides an effective means of improving oxygenation in severely hypoxaemic patients with P. carinii
pneumonia
.
...
PMID:Continuous positive airway pressure ventilation for respiratory failure associated with Pneumocystis carinii pneumonia. 188 30
A retrospective review was conducted of 22 human immunodeficiency virus type 1 (HIV-1)-infected children under 13 years of age presenting to an inner city pediatric emergency department to determine their clinical manifestations of disease and utilization of emergency department services. When compared with a population of 78 normal children, the infected children were more likely to present with cough, difficulty in breathing, and lethargy.
Pneumonia
, diarrhea, and dehydration were more common diagnoses in the infected children, who were more likely to be admitted, had more invasive procedures, and required more professional staff to provide care. There was no significant difference in the frequency of visits (visits/month of age) when comparing the two groups. As expected, the infected children presented with problems associated with pediatric
HIV
-1 infection. Our results suggest that
HIV
-1-infected children require an increased level of care in the emergency department and subsequent admission to the hospital. These children did not visit the emergency department more frequently than the controls. This may be the result of an active outpatient
HIV
clinic in our hospital, which is available to both scheduled and unscheduled patients.
...
PMID:Utilization and clinical manifestations of human immunodeficiency virus type 1-infected children presenting to a pediatric emergency department. 190 79
This study examines the impact of
HIV
-1 infection and AIDS on 500 of 563 consecutive deaths at University Hospital, Kinshasa, Zaire, in late 1987.
HIV
-1 seroprevalence was 31% for the entire population and 43% for the 247 adults. Forty-two (38%) of the 110
HIV
-1-seropositive adult deaths occurred in those between the ages of 25 and 34 years. The mean age of death for seropositives was 36 years, 7.5 years less than seronegative deaths. AIDS and AIDS-associated diagnoses such as cryptococcal meningitis, chronic diarrhea and
pneumonia
accounted for 42% of all adult deaths and 74% of all
HIV
-1-seropositive adult deaths. Seventeen per cent of 50 sera initially negative by enzyme-linked immunosorbent assay (ELISA) were ultimately found to be
HIV
-1-seropositive by Western blot or p24 antigen testing. The data indicate that
HIV
-1 infection and AIDS contribute significantly to adult mortality in Kinshasa population and that sensitivity of ELISA tests decreases in terminal
HIV
-1 infection.
...
PMID:HIV-1 seropositivity and mortality at University Hospital, Kinshasa, Zaire, 1987. 190 62
A 56-year-old man was admitted with hemiparesis and shortness of breath. He was positive to human immunodeficiency virus (HIV) antibody and was diagnosed as acquired immunodeficiency syndrome (AIDS) with Kaposi's sarcoma and pneumocystis carinii
pneumonia
. He developed chronic photosensitivity and vitiligo preceding the onset of the AIDS-related complex (ARC). Association of the two skin lesions with
HIV infection
is very rare. Although the role of
HIV infection
in these skin lesions is not significant, the immunological responses in the early course of
HIV infection
may have contributed to the development of both of these skin lesions.
...
PMID:Vitiligo and chronic photosensitivity in human immunodeficiency virus infection. 192 Sep 68
A 21 year old homosexual man presented with an acute
pneumonitis
during symptomatic seroconversion for human immunodeficiency virus (HIV-I) infection. The symptoms resolved spontaneously without any therapeutic interventions needed. Acute
pneumonitis
should be added to the ever-increasing spectrum of clinical manifestations in primary
HIV
-I infection.
...
PMID:Primary HIV-I infection associated with pneumonitis. 192 33
Zidovudine (azidothymidine, Retrovir) and ddI (di-deoxy-inosine, Videx) interfere with the multiplication of
HIV
by incorporation into nascent DNA chains and interruption of the further linking of nucleotides. Zidovudine lowers early mortality in patients with Aids and pneumocystis carinii
pneumonia
. However, much of the effectiveness of zidovudine is lost later on; the average prolongation of life in treated patients is estimated to be about 1 year. About two thirds of patients with Aids can be treated with zidovudine; in the others, the drug is ineffective or contraindicated. Frequent blood counts are necessary to monitor myelotoxicity, even at relatively low doses of 500 mg/day. In contrast, zidovudine is well tolerated by asymptomatic patients with 200 to 500 CD4 lymphocytes/mm3, in whom it diminishes the incidence of Aids from about 7 to 3% during the first year of treatment, with less than 2% severe anemia or leukopenia. For patients who do not tolerate zidovudine, ddI is an alternative. It is not myelotoxic but can cause neuritis and pancreatitis, especially at doses in excess of 10 mg/kg/day. Although its antiviral effect is excellent both in vitro and in vivo, there is still a lack of firm data on its clinical value, such as the decrease in opportunistic infections and increase in survival.
...
PMID:[Antiretroviral therapy in Switzerland 1991]. 192 47
Earlier diagnosis and improved therapies for the opportunistic infections have led to improved quality of life as well as survival time of patients with advanced
HIV
-related immunodeficiency. Most of the therapies can be administered on an outpatient basis. Outpatient treatment further contributes to improving the quality of life of the patients. Presentation, clinical aspects, treatment and prophylaxis of the five most frequent opportunistic infections in
HIV
-infected patients with advanced immunodeficiency in our outpatient clinic (oral and esophageal candidiasis, pneumocystis carinii
pneumonia
, herpes zoster, herpes simplex virus infection and cerebral toxoplasmosis) are discussed with respect to the practical implications.
...
PMID:[Ambulatory therapy and prevention of the most frequent HIV-associated opportunistic infections]. 192 48
We report a case of an
HIV
-infected adult with Chlamydia pneumoniae. Our patient presented with a clinical picture suggestive of Pneumocystis carinii pneumonia (PCP), but did not respond to empiric anti-PCP therapy. The diagnosis was eventually confirmed by bronchoscopy and serology. C. pneumoniae
pneumonia
should be considered in the differential of pathogens that cause interstitial infiltrates in
HIV
-infected persons.
...
PMID:Case report: Chlamydia pneumoniae pneumonia in an HIV-infected man. 192 25
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>